Loading organizations...
Loading organizations...
Next-generation precision oncology treatments developer.
Flindr Therapeutics has raised $21.4M across 1 funding round.
Flindr Therapeutics has raised $21.4M in total across 1 funding round.
Flindr Therapeutics has raised $21.4M in total across 1 funding round.
Flindr Therapeutics's investors include Christina Takke, BOM, Curie Capital, Tine Bekaert, Johnson & Johnson Innovation, Chris De Jonghe, Cedric Van Nevel, Swanbridge Capital.
Flindr Therapeutics has raised $21.4M across 1 funding round. Most recently, it raised $21.4M Series A in April 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 24, 2024 | $21.4M Series A | Christina Takke | BOM, Curie Capital, Tine Bekaert, Johnson & Johnson Innovation, Chris De Jonghe, Cedric Van Nevel, Swanbridge Capital |